Saliva Insulin as Biomarker of Risk Factors for Metabolic Dysregulation and Caries
1 other identifier
interventional
105
1 country
1
Brief Summary
Saliva insulin shows promise as a non-invasive biomarker of high carbohydrate intake and/or insulin resistance, key risk factors for metabolic dysregulation and caries. Saliva insulin monitoring could potentially inform the planning and evaluation of interventions to prevent child obesity, diabetes and caries, without relying on self-reported measures from children, parents, child care providers or teachers. School-based public health screening programs, which have staff and data collection infrastructure in place to regularly and systematically collect saliva during oral health screening, have opportunity to monitor saliva insulin. This randomized controlled trial explores if saliva insulin is responsive to the kinds of obesity and caries intervention currently in progress in schools, namely drinking water intervention. Public health programs may justify adding saliva collection to protocol already in place if saliva insulin data are found to be actionable, i.e. sensitive to risk and intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2021
CompletedFirst Posted
Study publicly available on registry
January 27, 2022
CompletedStudy Start
First participant enrolled
October 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 29, 2024
CompletedFebruary 25, 2026
February 1, 2026
1.2 years
December 17, 2021
February 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Lower saliva insulin after drinking water compared to juice; compared to no drink
Lower mean saliva insulin; Greater relative odds of saliva insulin below 5mU/I
1 hour
Secondary Outcomes (4)
Different untargeted metabolomic profile after drinking water compared to juice; and after drinking water compared to no drink
1 hour
Higher saliva pH (potential of hydrogen) after drinking water than after apple juice or no drink
1 hour
Higher saliva buffering capacity after drinking water than after apple juice or no drink
1 hour
Significantly higher saliva secretory immunoglobin a (IgA) after drinking water than after apple juice or no drink
1 hour
Study Arms (3)
No drink
NO INTERVENTIONControl; Participants will receive no drink
Drinking water
EXPERIMENTALIntervention drink; Participants will receive 500 ml drinking water from the San Francisco tap (i.e. fluoridated tap water). 500 ml is the standard bottle size.
Apple juice
ACTIVE COMPARATORIntervention drink; Participants will receive 200 ml box of apple juice. 200 ml is the standard serving usually available to this study population in the school setting
Interventions
The intervention will compare the effects of a usual serving of drinking water with the effects of a usual serving of apple juice. Both beverages will also be assessed relative to the effects of not drinking anything at all.
Eligibility Criteria
You may qualify if:
- UCSF Pediatric Dental Clinic patients New patient exam or recall exams Caregiver and child speak English, Spanish or Chinese Ages 5-10 years San Francisco residents Non-acutely ill (healthy enough to attend school, no fever and no systemic conditions)
You may not qualify if:
- Child and caregiver do not speak English, Spanish or Chinese Not a San Francisco resident Under age 5 years Over age 10 years Child unwilling to accept randomized drink assignment Child unable or unwilling to drink water or apple juice Child unable or unwilling to give saliva Child is presenting to the dental clinic for an operative procedure Acute illness, fever, infection or condition that would prevent the child from attending school No remaining space in study group (weight-specific recruitment is complete).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jodi Stookeylead
Study Sites (1)
UCSF Pediatric Dentistry
San Francisco, California, 94143, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jodi Stookey, PhD
San Francisco Department of Public Health
- PRINCIPAL INVESTIGATOR
Thomas Tanbonliong, DDS
University of California, San Francisco
- PRINCIPAL INVESTIGATOR
Mimansa Cholera, DDS
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The participant will know what group they are assigned to as they will see and taste the assigned beverage. The investigator who assigns participants to a treatment group will not administer the beverage or collect data. The investigator who administers the beverage will know the group assignment. The laboratory staff who assess the outcomes will not know the assignment.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MCAH Senior Epidemiologist
Study Record Dates
First Submitted
December 17, 2021
First Posted
January 27, 2022
Study Start
October 12, 2022
Primary Completion
December 31, 2023
Study Completion
January 29, 2024
Last Updated
February 25, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share